Abstract
Lung cancer is the leading cause of cancer related mortality worldwide. Crocetin, saffron plant derivative known to play a role in cancer chemoprevention. In the present study the effects of crocetin was tested against lung cancer-bearing mice in both pre-initiation and post-initiation periods. Healthy male Swiss albino mice (6–8 weeks old) were used throughout the study. Experiment was designed with the treatment regimen of crocetin [20 mg/kg body weight dissolved in dimethyl sulphoxide (DMSO)] for 4 weeks before (pre-initiation) and from 12th week after Benzo(a) pyrene B(a)p (50 mg/kg body weight) induced lung carcinoma(post-initation). The level of lipid peroxidation (LPO) and marker enzymes markedly increased in carcinogen administered animals, which was brought back to near normal by crocetin treatment. The activities of the enzymic antioxidants and glutathione metabolizing enzymes were decreased in B(a)p induced animals and increased upon drug treatment. Crocetin profoundly reverted back the pathological changes observed in cancerous animals. From the results crocetin proves to scavenge free radical and plays an important role in cellular function. Tumor incidence and histopathological studies proves crocetin is a potent antitumour agent.
Similar content being viewed by others
References
Hans peter W, Deuter M, Imilda E: Chemoprevention of tobacco smoke induced lung carcinogenesis in mice. Carcinogenesis 21: 977–82, 2000
Anto RJ, Mukhopadyah A, Denning K, Aggarwal BB: Curcumin induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23: 143–50, 2002
Stephen S, Pramod Upadhaya, Mingyao Wang, Robin L. Bliss, Edward J. Mcintee,Patrick MJ Kenney: Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L- cysteine and myo-inositol, individually and in combination. Carcinogenesis 29: 1455–1461, 2002
Demming-Adams B, Gilmore AM,Adams WW: In Vivo Functions Of Carotenoids In Higher Plants, FASEB Journal 10: 403–412, 1996
Jagadeswaran R, Thirunavukkarasu C, Gunasekaran P, Nalini Ramamurthy, Sakthisekaran D: In vitro studies on the selective cytotoxic effect of crocetin and quercetin. Fitoterapia 71: 395–399, 2000
Abdullaev FI: Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus,L). Exptl Biol Med 227: 20–5, 2002
Chang VC, Lin YL, Lee MJ, Show SJ, Wang CJ: Inhibitory effect of crocetin on benzo(a)pyrece genotoxicity and neoplastic transformation in C3H1OT1/2 cells. Anticancer Res 765: 3603–3608, 1996
Nair SC, Pannikar B, Pannikar KR: Antitumour activity of saffron (Crocus sativus). Cancer Lett 57: 109–14, 1991
Salomi MJ, Nair SC, Panikkar PR: Cytotoxicity and nonmutagenicity of Nigela sativa and saffron(Crocus sativus) in vitro. Proc Ker Congr 5: 244, 1991
Tarantilis PA, Tsoupras G, Polissiou M: Determination of saffron(Crocus sativus, L) components in crude plant extract using HPLC-U V Visible photodiode-array detection-mass spectrometry. J Chromatography 699: 107–18, 1995
Daly ES: Protective effect of cystein and vitamin A, Crocus sativus and Nigela sativa extracts on cysplatin induced toxicity inrats. J Pharm Belg 53: 93–5, 1998
Guyton KZ, Kensler TW: Oxidative mechanisms in carcinogenesis. Brit Med Bull 49: 523–544, 1993
Cross CE, Halliwell B, Borish ET: Oxygen radicals and human disease proceedings of a conference). Ann Intern Med 107: 526–545, 1987
Kidd PM: Natural antioxidants—first line of defense. In: Kidd PM, Huber W. Living with the AIDS Virus: A Strategy for Long-Term Survival. Albany, California: PMK Biomedical-Nutritional Consulting 115–142, 1991
Stephen S, Pramod Upadhaya, Mingyao Wang, Robin L, Bliss, Edward J Mcintee and Patrick MJ Kenny: Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)–L-cysteine and myoinositol, individually and in combination.Carcinogenesis 29(9): 1455–1461, 2002
Dodge JT, Mitchell C, Hanahan DJ: The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100: 119–30, 1963
Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal. Biochem 95: 351–358, 1979
Habig WH, Pabst MJ, Jacoby WB: Glutathione-Stransferase : The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–39, 1974
Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization oferythrocyte glutathione peroxidase. J Lab Clin Med 70: 158–169, 1967
Luck H: A spectrophotometric method for the estimation of catalase: In Bergmeyer, H.V. (ed) Methods of enzymatic analysis, Acad. Press, New York, pp. 886–888, 1963
Marklund S,Marklund G: Involvement of the superoxide anion radical in the auto oxidationof pyrogallol and a convenient assay for superoxide dismutase. Europ J Biochem 47: 469–474, 1974
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin's phenol reagent. J. Biol. Chem 193: 265–276, 1951
Mildred K, Richerd L, Joseph G, Alexander W,Conney A: Activation and inhibition of Benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally accruing flavonoids. Cancer Res 41: 67–72, 1981
Orlowski K,Meister A: Isolation of γ-glutamyl transpeptidase from hog kidney. J. Biol. Chem 240: 338–347, 1965
Rosalki,Rao, Serum γ glutamyl transpeptidase activity in alcoholism: Clin Chim Acta 39: 41–47, 1972
Luly P, Barnabei O,Tria E: Hormonal control in vitro of plasma membrane bound Na+/K+ ATPase of rat liver. Biochem Biophys Acta 282: 447–452, 1972
King J: In: Practical Clinical Enzymology. D. van. Nostrand Co., London, 83–93, 1965
Staal GEJ, Visser J,Veeger C: Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta 185: 39–48, 1969
Moron MS, DePierre JW,Manerwik KB: Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582: 67–68, 1979
Luna LG: Manual of Histological staining. Methods of Armed forces. Institute of Pathology, London, pp.1–31, 1966
Unnikrishnan MC,Kuttan R: Tumor reducing and anticarcinogenic activity of selected spices. Cancer Lett 51: 85, 1990
Williams GW: Modulation of chemical carcinogenesis by xenobiotics. Fund Appl Toxicol 4: 325–44, 1984
Wattenberg LW: Chemoprevention of cancer. Cancer Res 45: 1–8, 1985
Boone CW, Kelloff GJ, Malone WE: Identification of cancer chemotherapy agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50: 2–9, 1990
Bauer G,Wendel A: The activity of the peroxidemetabolising system in human colon carcinoma. Cancer Res Clin Oncol 97: 267–73, 1980
Sikkim Jun H, Kwack S, Lee BM: Lipid peroxidation, antioxidant enzymes and Benzo(a)pyrenequinones in the blood of rats treated with benzo(a)pyrene. Chem Biol Ineract 127: 139–50, 2000
Tessitore L, Costelli P,Baccino MF: Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem J 299: 71–78, 1994
Pain VM, Randall DP,Garlick PJ: Protein synthesis in liver and skeletal muscle of mice bearing ascites tumour. Cancer Res 44: 1054–1057, 1984
Eric Yarnell ND: Carotenoids Continuing Education Module Natural Healing Track, 1–8, 1999
Yay TM: Mutagenecity and cytotoxicity of malonaldehyde in mammalian cells. Mech Ageing Dev 11: 137–44, 1979
Apaja M: Evaluation of toxicity and carcinogenity of malonaldehyde. An experimental study in swiss mice. Thesis Acta Univ Ouluensis, Ser D 55, 1980
Basu AK,Marnett JL: Uniquivocal demonstration that malonaldehyde is a mutagen. Carcinogenesis 4: 331–3, 1983
Van Popper, G: Carotenoids and Cancer: an update with emphasis on human intervention studies. Eur J Cancer 294: 1335–1344, 1993
Wood JL: In Metabolic Conjugation and Metabolic hydrolysis (Fishman, W.H. ed.,) AcademicPress New York, 2, pp. 261–299, 1970
Kraemer KH, Di Giovanna J, Moshell N: Prevention of skin cancer in xeroderma pigmentosum. N Engl J Med 318: 1633–1637, 1988
Sunde RA,Hoekstra WG: Structure, synthesis, and function of Glutathione peroeidase. NutrRev 8: 265–273, 1980
Singh I: Mammalian peroxisomes: metabolism of oxygen and reactive oxygen species. Ann N Y Acad Sci 804: 612–627, 1996
Moser HW, Moser AB: Peroxisomal disorders: overview. Ann N Y Acad Sci 804: 427–441, 1996
Prince Vijeya Singh J, Selvendiran K, Mumtaz Banu S, Padmavathi R,Sakthisekaran D: Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatpcarcinogenesis in Wister albino rats. Phytomedicine 11: 309–314, 2004
Ilan Y, Rabani J: Superoxide dismutase activity of an iron porphyrin. Inorg. Nuclear Chem Lett 17, 93–96, 1981
Perego P, Gatti L, Carenini N, Dal Bo L, Zunino F: Apoptosis induced by extra cellular glutathione is mediated by H2O2 production and DNA damage. Int JCancer 87: 343–348, 2000
Mikhail F, Denissenko K, Annie P, Moon-shong T, Gerd PP: Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p. 53. Science 274: 430– 432, 1996
Stefanini, M: Enzymes, isoenzymes and enzyme variants in the diagnosis of cancer. Cancer55: 1931–1936, 1985
Yildrim Z, Hasanoglu C, Omer Okyol HJ, Gokirmakan S, Koksal N: Serum adenosine deaminaseactivities in LC and mesothelioma Clin Biochem 32: 283–285, 1999
Valentich AM, Moris B: Effects of essential fatty acid deficiency on GGT activity of ratpancreas. J Nutr Biochem 3: 67–70, 1992
Vanishree AJ, Shyamaladevi CS: Effect of therapeutic strategy estimatedby N-acetyl cysteine and Vit C on the activities of tumor marker enzymes in vitro Ind J Pharmacol 31: 275–278, 1998
Lippert M, Papadopoulos N, Javadpour NR: Role of lactate dehydrogenase isoenzymes in testicular cancer. Urology 18: 50–53, 1981
Mirmomeni MH, Suzanger M, Wise A, Messripour M, Emami H: Biochemical studies during AFB,induced liver damage in rats fed different levels of dietary protein. Int J Cancer 24: 471–476, 1979
Engan T, Hannisdal E: Blood analyses as prognostic factors in primary lung cancer. Acta Oncol 29: 151–154, 1990
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magesh, V., Singh, J.P.V., Selvendiran, K. et al. Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem 287, 127–135 (2006). https://doi.org/10.1007/s11010-005-9088-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9088-0